These present and previous findings may explain why laboratory markers of dengue severity (excluding ALT level during the febrile phase) and LOS were not significantly different between the no leakage-NAFLD and no leakage+NAFLD groups in this study. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.